logo
Plus   Neg
Share
Email

Biogen To Acquire Clinical Stage PF-05251749 From Pfizer - Quick Facts

Biogen Inc. (BIIB) announced an agreement to acquire from Pfizer Inc. (PFE) PF-05251749, a CNS-penetrant small molecule inhibitor of casein kinase 1, for the potential treatment of patients with behavioral and neurological symptoms across various psychiatric and neurological diseases. The deal will include an upfront payment of $75 million with up to $635 million in potential additional development and commercialization milestone payments, as well as tiered royalties in the high single digits to sub-teens.

PF-05251749 has previously demonstrated an acceptable safety profile and proof of mechanism in a phase 1a clinical study. Biogen plans to develop this asset for the treatment of Sundowning in Alzheimer's disease and Irregular Sleep Wake Rhythm Disorder in Parkinson's disease. The company aims to initiate a phase 1b study in the fourth quarter of 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook Inc. said it will ban ads that seek to delegitimize the Presidential election. The announcement is in line with the social media giant's decision to prohibit ads that make premature declarations of victory as it aims to protect the integrity of the upcoming U.S. 2020 elections. Rob Leathern, Director of Product Management, in a tweet said that these changes apply to ads across Facebook... While reporting financial results for the first quarter of fiscal 2021 on Thursday, Conagra Brands, Inc. (CAG) provided only its adjusted earnings and organic net sales growth guidance for the second quarter of fiscal 2021. The company is still not initiating annual outlook, as is usual, as the impact... Playboy Enterprises, Inc. and Mountain Crest Acquisition Corp. (MCAC) announced Thursday the signing of a definitive merger agreement to return Playboy to the public markets. They also signed definitive purchase agreements with institutional and accredited investors for the purchase of $50 million of...
Follow RTT